[HTML][HTML] The role of microRNAs in neurodegenerative diseases: a review
S Li, Z Lei, T Sun - Cell Biology and Toxicology, 2023 - Springer
MicroRNAs (miRNAs) are non-coding RNAs which are essential post-transcriptional gene
regulators in various neuronal degenerative diseases and playact a key role in these …
regulators in various neuronal degenerative diseases and playact a key role in these …
[HTML][HTML] Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases
YY Wu, HC Kuo - Journal of Biomedical Science, 2020 - Springer
Recent transcriptome analyses have revealed that noncoding RNAs (ncRNAs) are broadly
expressed in mammalian cells and abundant in the CNS, with tissue and cell type-specific …
expressed in mammalian cells and abundant in the CNS, with tissue and cell type-specific …
Identification of a protective microglial state mediated by miR-155 and interferon-γ signaling in a mouse model of Alzheimer's disease
Z Yin, S Herron, S Silveira, K Kleemann… - Nature …, 2023 - nature.com
Microglia play a critical role in brain homeostasis and disease progression. In
neurodegenerative conditions, microglia acquire the neurodegenerative phenotype (MGnD) …
neurodegenerative conditions, microglia acquire the neurodegenerative phenotype (MGnD) …
Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology
Polygenic risk scores have identified that genetic variants without genome‐wide significance
still add to the genetic risk of developing Alzheimer's disease (AD). Whether and how …
still add to the genetic risk of developing Alzheimer's disease (AD). Whether and how …
[HTML][HTML] MiR-155: an important regulator of neuroinflammation
VD Zingale, A Gugliandolo, E Mazzon - International Journal of Molecular …, 2021 - mdpi.com
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression
at the post-transcriptional level and that play an important role in many cellular processes …
at the post-transcriptional level and that play an important role in many cellular processes …
[HTML][HTML] PICALM and Alzheimer's disease: an update and perspectives
K Ando, S Nagaraj, F Küçükali, MA De Fisenne… - Cells, 2022 - mdpi.com
Genome-wide association studies (GWAS) have identified the PICALM (Phosphatidylinositol
binding clathrin-assembly protein) gene as the most significant genetic susceptibility locus …
binding clathrin-assembly protein) gene as the most significant genetic susceptibility locus …
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease
Alzheimer's disease (AD) is a multifaceted, advancing neurodegenerative illness that is
responsible for most cases of neurological impairment and dementia in the aged population …
responsible for most cases of neurological impairment and dementia in the aged population …
[HTML][HTML] Tau Isoforms: Gaining Insight into MAPT Alternative Splicing
A Corsi, C Bombieri, MT Valenti… - International Journal of …, 2022 - mdpi.com
Tau microtubule-associated proteins, encoded by the MAPT gene, are mainly expressed in
neurons participating in axonal transport and synaptic plasticity. Six major isoforms …
neurons participating in axonal transport and synaptic plasticity. Six major isoforms …
[HTML][HTML] The role of the transcription factor Nrf2 in Alzheimer's disease: therapeutic opportunities
LM De Plano, G Calabrese, MG Rizzo, S Oddo… - Biomolecules, 2023 - mdpi.com
Alzheimer's disease (AD) is a common neurodegenerative disorder that affects the elderly.
One of the key features of AD is the accumulation of reactive oxygen species (ROS), which …
One of the key features of AD is the accumulation of reactive oxygen species (ROS), which …
[HTML][HTML] MicroRNAs in Alzheimer's disease: function and potential applications as diagnostic biomarkers
W Wei, ZY Wang, LN Ma, TT Zhang, Y Cao… - Frontiers in molecular …, 2020 - frontiersin.org
Alzheimer's disease (AD) is the most common form of dementia. Although the incidence of
AD is high, the rates of diagnosis and treatment are relatively low. Moreover, effective means …
AD is high, the rates of diagnosis and treatment are relatively low. Moreover, effective means …